AI assistant
Sending…
Wave Life Sciences Ltd. — Director's Dealing 2015
Nov 11, 2015
31900_dirs_2015-11-10_e2c44083-9471-4384-aa90-2297c5290019.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2015-11-10
Reporting Person: GUERCIOLINI ROBERTO (See Remarks)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Share Option (Right to Buy) | $2.474 | 2025-03-22 | Ordinary Shares (108617) | Direct | |
| Share Option (Right to Buy) | $2.474 | 2025-03-22 | Ordinary Shares (12629) | Direct |
Footnotes
F1: The share option will vest as to 25% of the shares underlying such option on March 10, 2016 and the remaining shares will vest in thirty-six equal monthly installments thereafter.
F2: The share option will vest as to 25% of the shares underlying such option on March 10, 2016 and the remaining shares will vest in thirty-six equal monthly installments thereafter.
More from Wave Life Sciences Ltd.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 15
Major Shareholding Notification
2026
Mar 31
Director's Dealing
2026
Mar 31
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 28
Annual Report
2026
Feb 26